🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Nektar Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
52.1955.2398.4390.1292.06101.91
Revenue Growth
-16.64%-43.89%9.21%-2.10%-9.67%-33.36%
Cost of Revenue
--30.6933.7721.6424.9
Gross Profit
52.1955.2367.7456.3570.4277.01
Selling, General & Admin
61.9668.6776.7577.4292.33122.84
Research & Development
148.64117.33120.91114.16218.32400.27
Operating Expenses
210.6186197.66191.58310.66523.11
Operating Income
-158.42-130.77-129.92-135.23-240.24-446.1
Interest Expense
-31.68-26.18-28.11-25.33-28.91-47.31
Interest & Investment Income
25.9410.4414.519.016.782.73
Earnings From Equity Investments
-4-8.73----
Other Non Operating Income (Expenses)
-0.540.36-0.39-1.1533.31-8.19
EBT Excluding Unusual Items
-168.69-154.88-143.92-142.7-229.05-498.87
Merger & Restructuring Charges
-8.45-9.33-15.67-51.96-135.93-
Impairment of Goodwill
----76.5--
Gain (Loss) on Sale of Assets
--40.39-5.1--
Other Unusual Items
------24.41
Pretax Income
-177.14-164.21-119.2-276.26-364.98-523.28
Income Tax Expense
0.12-0.14-0.24-0.23.220.56
Net Income
-177.26-164.08-118.96-276.06-368.2-523.84
Net Income to Common
-177.26-164.08-118.96-276.06-368.2-523.84
Net Income Growth
------
Shares Outstanding (Basic)
281714131212
Shares Outstanding (Diluted)
281714131212
Shares Change
83.87%23.05%8.24%1.53%2.10%2.64%
EPS (Basic)
-6.31-9.73-8.68-21.79-29.51-42.87
EPS (Diluted)
-6.31-9.73-8.68-21.79-29.55-42.90
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-258.18-209.38-177.18-193.47-309.68-427.65
Free Cash Flow Per Share
-9.19-12.41-12.92-15.27-24.82-35.00
Gross Margin
100.00%100.00%68.82%62.53%76.50%75.57%
Operating Margin
-303.57%-236.77%-131.99%-150.05%-260.97%-437.76%
Profit Margin
-339.67%-297.07%-120.86%-306.31%-399.98%-514.03%
Free Cash Flow Margin
-494.74%-379.09%-180.01%-214.68%-336.41%-419.65%
EBITDA
-157.75-129.75-125.53-127.41-227.21-431.96
EBITDA Margin
--234.91%-127.53%-141.38%-246.81%-
D&A For EBITDA
0.671.034.397.8213.0314.15
EBIT
-158.42-130.77-129.92-135.23-240.24-446.1
EBIT Margin
--236.77%-131.99%-150.05%-260.97%-
Revenue as Reported
52.1955.2398.4390.1292.06101.91
SEC Filings: 10-K · 10-Q